Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Prescribing of Benzodiazepines
The U. S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the safe tapering of benzodiazepines.
Applicants must propose a comprehensive evidence-based plan that advances safe tapering of benzodiazepines.
Applicants must propose a comprehensive evidence-based plan that advances safe tapering of benzodiazepines.
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Estimated Funding: $4,420,000
Office: Food and Drug Administration
Estimated Funding: $4,420,000
Who's Eligible
Obtain Full Opportunity Text:
FULL ANNOUNCEMENT
Additional Information of Eligibility:
This program provides all 50 states, the District of Columbia, 2 American Indian Tribes, 5 U. S. Territories, and 3 Freely Associated States as identified in the authorizing statute with funding to address their own unique public health needs and challenges with innovative and locally defined methods.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-027.html
Contact:
Agency Email Description:
shashi.malhotra@fda.hhs.gov
Agency Email:
Date Posted:
2022-06-01
Application Due Date:
Archive Date:
2022-09-02
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
